B Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1 - CISMeF
B Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1NCIt concept
Preferred Label : B Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1;
NCIt synonyms : B-Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34;q11.2); BCR-ABL1; B Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34;q11.2); BCR-ABL1; B Lymphoblastic Leukemia Lymphoma with t 9 22 q34 q11 2 BCR-ABL 1; B Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR::ABL1; B Lymphoblastic Leukemia/Lymphoma with BCR-ABL1 Fusion; B Lymphoblastic Leukemia/Lymphoma with BCR::ABL1 Fusion; B-Lymphoblastic Leukemia/Lymphoma with BCR-ABL1 Fusion; B-Lymphoblastic Leukemia/Lymphoma with BCR::ABL1 Fusion;
NCIt definition : A precursor lymphoid neoplasm which is composed of B lymphoblasts and carries a translocation
between the BCR gene on chromosome 22 and the ABL1 gene on chromosome 9. It results
in the production of the p190 kd or p210 kd fusion protein. It has an unfavorable
clinical outcome.;